Wachholz B W
Radiation Effects Branch, National Cancer Institute, Bethesda, MD 20892.
Health Phys. 1990 Nov;59(5):511-4. doi: 10.1097/00004032-199011000-00002.
The Department of Health and Human Services (DHHS) was directed by Congress to assess the risk of thyroid cancer from 131I associated with fallout from the atmospheric testing of nuclear weapons at the Nevada Test Site. The National Cancer Institute (NCI) was requested by DHHS to address Public Law 97-414, Section 7 (a), which directs DHHS to "(1) conduct scientific research and prepare analyses necessary to develop valid and credible assessments of the risks of thyroid cancer that are associated with thyroid doses of Iodine 131; (2)...develop...methods to estimate the thyroid doses of Iodine 131 that are received by individuals from nuclear bomb fallout; (and) (3)...develop...assessments of the exposure to Iodine 131 that the American people received from the Nevada atmospheric nuclear bomb tests." In addition, the University of Utah, under contract with the NCI, is carrying out a study to determine if the incidence of thyroid disease and leukemia among identified populations in Utah may be related to exposure from fallout originating at the Nevada Test Site.
美国卫生与公众服务部（DHHS）受国会指示，评估内华达试验场核武器大气层试验产生的放射性沉降物中131I所致甲状腺癌的风险。DHHS要求美国国家癌症研究所（NCI）处理公法97 - 414第7（a）节的要求，该节指示DHHS“(1) 开展科学研究并进行分析，以对与131I甲状腺剂量相关的甲状腺癌风险进行有效且可信的评估；(2)……制定……方法，以估算个人从核弹沉降物中所接受的131I甲状腺剂量；以及(3)……制定……对美国民众从内华达大气层核弹试验中所接受的131I暴露情况的评估。”此外，犹他大学根据与NCI签订的合同，正在开展一项研究，以确定犹他州特定人群中甲状腺疾病和白血病的发病率是否可能与源自内华达试验场的沉降物暴露有关。
